TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+5.2%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$619M
AUM Growth
+$619M
(+3.4%)
Cap. Flow
+$539K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
39.21%
Holding
86
New
4
Increased
25
Reduced
34
Closed
1
Top Buys
| 1 |
Nektar Therapeutics
NKTR
|
$1.35M |
| 2 |
Stratasys
SSYS
|
$939K |
| 3 |
Analog Devices
ADI
|
$762K |
| 4 |
Schlumberger
SLB
|
$677K |
| 5 |
CRC
California Resources Corporation
CRC
|
$374K |
Top Sells
| 1 |
Coca-Cola Femsa
KOF
|
$2.15M |
| 2 |
Biogen
BIIB
|
$1.66M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
$1.54M |
| 4 |
SYT
Syngenta Ag
SYT
|
$629K |
| 5 |
GE Aerospace
GE
|
$477K |
Sector Composition
| 1 | Healthcare | 35.91% |
| 2 | Technology | 14.28% |
| 3 | Industrials | 11.45% |
| 4 | Consumer Staples | 9.2% |
| 5 | Energy | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIF
1
DELISTED
Tiffany & Co.
TIF
| $37.8M | 6.11% |
353,751
+415
| +0.1% | +$44.3K |
|
|
2
Biogen
BIIB
$19.4B
| $36.5M | 5.89% |
107,389
-4,900
| -4% | -$1.66M |
|
3
Johnson & Johnson
JNJ
$427B
| $23.9M | 3.87% |
228,962
-924
| -0.4% | -$96.6K |
|
4
Brown-Forman Class B
BF.B
$14.2B
| $23M | 3.72% |
261,722
+962
| +0.4% | +$84.5K |
|
5
Danaher
DHR
$147B
| $21.7M | 3.51% |
253,482
-1,195
| -0.5% | -$102K |
|
6
Cognex
CGNX
$7.38B
| $21.5M | 3.48% |
521,220
+2,830
| +0.5% | +$117K |
|
|
7
Stratasys
SSYS
$906M
| $20.9M | 3.38% |
251,877
+11,300
| +5% | +$939K |
|
8
W.W. Grainger
GWW
$48.5B
| $19.5M | 3.15% |
76,485
+545
| +0.7% | +$139K |
|
|
9
Analog Devices
ADI
$124B
| $19.4M | 3.14% |
349,464
+13,730
| +4% | +$762K |
|
10
Neogen
NEOG
$1.25B
| $18.1M | 2.92% |
364,867
+4,170
| +1% | +$207K |
|
11
Novo Nordisk
NVO
$251B
| $17.4M | 2.81% |
410,755
+3,685
| +0.9% | +$156K |
|
12
Honeywell
HON
$139B
| $17.2M | 2.78% |
172,410
-1,820
| -1% | -$182K |
|
|
13
Schlumberger
SLB
$55B
| $17.2M | 2.78% |
201,545
+7,923
| +4% | +$677K |
|
|
RTN
14
DELISTED
Raytheon Company
RTN
| $16.1M | 2.6% |
148,487
-2,265
| -2% | -$245K |
|
15
Amgen
AMGN
$155B
| $15.4M | 2.49% |
96,737
-990
| -1% | -$158K |
|
16
DexCom
DXCM
$29.5B
| $15.1M | 2.44% |
274,275
-450
| -0.2% | -$24.8K |
|
17
Henry Schein
HSIC
$8.44B
| $15M | 2.43% |
110,305
+900
| +0.8% | +$123K |
|
18
Idexx Laboratories
IDXX
$51.8B
| $13.9M | 2.24% |
93,520
-10
| -0% | -$1.48K |
|
|
SYT
19
DELISTED
Syngenta Ag
SYT
| $13.2M | 2.13% |
205,397
-9,795
| -5% | -$629K |
|
20
Insulet
PODD
$23.9B
| $12.5M | 2.02% |
270,925
+100
| +0% | +$4.61K |
|
|
CTXS
21
DELISTED
Citrix Systems Inc
CTXS
| $12.1M | 1.96% |
190,406
-5,132
| -3% | -$327K |
|
22
Williams-Sonoma
WSM
$23.1B
| $11.4M | 1.84% |
150,580
+1,300
| +0.9% | +$98.4K |
|
|
23
Nektar Therapeutics
NKTR
$568M
| $10.7M | 1.73% |
690,641
+87,200
| +14% | +$1.35M |
|
24
Trimble
TRMB
$19.2B
| $10.4M | 1.67% |
390,135
+7,220
| +2% | +$192K |
|
|
25
GE Aerospace
GE
$292B
| $9.35M | 1.51% |
370,168
-18,890
| -5% | -$477K |
|